April 4, 2025 03:36 PM EDT
Pharma
Law

GSK and Pfiz­er re­solve RSV vac­cine patent fight

Nicole DeFeudis

Editor

GSK and Pfiz­er have set­tled a law­suit al­leg­ing Pfiz­er’s RSV shot Abrys­vo in­fringed GSK’s patents.

A Pfiz­er spokesper­son told End­points News that as part of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump ad­min­is­tra­tion leaves obe­si­ty cov­er­age ex­pan­sion out of new Medicare rule

Se­cre­tive Chi­nese start­up be­gins first-ever clin­i­cal tri­al of cir­cu­lar RNA ther­a­py

Marks was asked to pro­vide non-ex­is­tent vac­cine risk da­ta: WSJ

No­vavax’s held-up ap­proval pack­age may sig­nal warn­ing for Covid vac­cine mak­ers

Kennedy team de­fends Marks fir­ing, while 20% of staff cuts may be 'mis­takes'

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times